Mesothelin expression in esophageal adenocarcinoma and squamous cell carcinoma and its possible impact on future treatment strategies

BACKGROUND: Mesothelin is expressed at very low levels by normal mesothelial cells but is overexpressed in several human cancers. This makes mesothelin a promising target for immunotherapy. Limited data exist about mesothelin expression in esophageal carcinoma. In a current clinical trial, the highl...

Descripción completa

Detalles Bibliográficos
Autores principales: Moentenich, Valeska, Comut, Erdem, Gebauer, Florian, Tuchscherer, Armin, Bruns, Christiane, Schroeder, Wolfgang, Buettner, Reinhard, Alakus, Hakan, Loeser, Heike, Zander, Thomas, Quaas, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249595/
https://www.ncbi.nlm.nih.gov/pubmed/32547645
http://dx.doi.org/10.1177/1758835920917571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249595/
https://www.ncbi.nlm.nih.gov/pubmed/32547645
http://dx.doi.org/10.1177/1758835920917571

Ejemplares similares